How long does tirzepatide last per dose — and what does that mean for you?

Why does a five-day half-life translate to a once-weekly injection?

Half-life tells you how long it takes for your body to reduce the concentration of a medicine by half. Tirzepatide's half-life sits at around five days, which means that by the time you are due your next injection, roughly one quarter of the previous dose is still present. That residual amount is enough to prevent any meaningful gap in effect. The once-weekly schedule is therefore not arbitrary convenience; it is designed to maintain a relatively flat concentration curve rather than the peaks and troughs you might expect from a medicine taken daily.

This matters practically because it is why missing a dose by a day or two is less catastrophic with tirzepatide than it might be with a shorter-acting medicine, though if you do miss an injection, always follow the guidance in your Patient Information Leaflet and discuss it with your prescriber rather than adjusting your own timing. For a fuller picture of how the medicine moves through the body after each injection, our page on how long tirzepatide stays in your system covers the pharmacokinetics in more detail.

The NHS medicines information for tirzepatide confirms the once-weekly dosing schedule and the biological basis for it. You can read the NHS tirzepatide page for patient-level detail on how the medicine works.

How quickly do effects build up, and when do most people notice a difference?

Because of that five-day half-life, tirzepatide accumulates gradually. Steady-state (the point where week-on-week blood levels stabilise) is generally reached somewhere between four and eight weeks of consistent injections. Before that, concentrations are still climbing with each new dose.

This partly explains why many people do not feel dramatic appetite changes in the first week or two. The medicine is present, but not yet at its working plateau. Clinical trials in the SURMOUNT programme (which enrolled thousands of adults) showed that meaningful weight reduction builds progressively over months rather than appearing suddenly. If you are curious about the timeline from first injection to noticeable change, our separate page on how long tirzepatide takes to work walks through the evidence week by week.

Treatment starts at 2.5 mg. That starting dose exists to let your digestive system adjust, not to deliver a full therapeutic effect, the appetite and weight changes that most people come for are associated with higher maintenance doses reached after a prescriber-guided titration. A quick check worth doing: around week four to six, many people find it useful to compare their hunger levels at the same time of day they would have eaten before treatment. Not a formal measure, just a reference point to share with your prescriber at review.

What happens to the effects once tirzepatide wears off or treatment stops?

Tirzepatide does not leave the body the moment your seven days are up, the gradual nature of its clearance means effects tail off over several weeks rather than cutting out sharply. At the same time, that slow decline means that if treatment is paused or stopped, the appetite-suppressing effects do not vanish overnight either.

What the evidence does show is that the weight-loss effects are tied to the medicine remaining active. Data from the SURMOUNT trials found that participants who discontinued tirzepatide regained a substantial portion of lost weight over the following months. The NICE technology appraisal of tirzepatide, NICE TA1026, addresses the question of continued treatment: NICE recommends reviewing whether to continue if weight loss is less than five per cent after six months at the highest tolerated dose.

For people who stop intentionally (because they have reached a target, because of side effects, or because circumstances change) the practical implication is a planned transition with prescriber support, not an abrupt end. How long tirzepatide's effects persist after the last dose is discussed in detail on our page about how long tirzepatide lasts in the body, including the timeline for full clearance.

Does the dose level change how long tirzepatide lasts?

The half-life itself stays consistent across Mounjaro's licensed UK doses (2.5 mg through to 15 mg) because that five-day figure reflects how the body processes the tirzepatide molecule, not how much of it is present. What changes with higher doses is not duration but intensity: more receptor activity, typically greater appetite suppression, and in clinical trials, greater average weight reduction. If you want to understand how long Mounjaro lasts at each stage of your treatment, our dedicated page breaks down what to expect dose by dose.

That said, higher doses also tend to bring more noticeable gastrointestinal side effects, particularly in the early weeks at a new dose level, nausea, changes in bowel habit, and a feeling of fullness that can make eating normally feel effortful. These effects are generally most pronounced in the days immediately after an injection and settle for most people as the weeks pass. They are covered thoroughly on the Mounjaro overview page if you want the full picture before starting.

Cost is a practical consideration for any medicine taken long-term. Our Mounjaro price guide sets out the cost context for private treatment in the UK, including what a legitimate price should cover. If you are considering starting treatment or switching provider, the practical next step is a clinical assessment, speak to our prescribers through a free consultation, and a GPhC-registered Independent Prescriber will review your situation the same day.